Table 5.
Variable | Univariate analysis
|
Multivariate analysis
|
||
---|---|---|---|---|
Crude odds ratio (95% CI) | p Value | Adjusted odds ratio (95% CI) | p Value | |
Age | 1.02 (0.99–1.06) | 0.22 | ||
| ||||
Male gender | 1.78 (0.63–5.05) | 0.28 | ||
| ||||
Diabetes | 0.60 (0.19–1.86) | 0.38 | ||
| ||||
ASA score | ||||
| ||||
2 | Reference | |||
| ||||
3 | 0.73 (0.27–1.97) | 0.53 | ||
| ||||
4 | 2.70 (0.60–12.20) | 0.20 | ||
| ||||
Platelet count <150/nL | 4.82 (1.91–12.15) | 0.001* | 4.62 (1.46–14.64) | 0.009* |
| ||||
Child score | 2.51 (1.68–3.74) | 0.001* | 2.42 (1.41–4.14) | 0.001* |
| ||||
MELD score | 1.10 (0.99–1.20) | 0.056 | 1.03 (0.88–1.21) | 0.715 |
| ||||
Ruptured lesion | 1.47 (0.31–6.98) | 0.63 | ||
| ||||
Tumor >Milan criteria | 9.17 (1.20–69.75) | 0.032* | 33.48 (3.31–339.02) | 0.003* |
| ||||
Major resection | 0.78 (0.32–1.91) | 0.58 |
Statistically significant p values.
ASA, American Society of Anesthesiologists; MELD, model for end-stage liver disease.